Results 11 to 20 of about 21,938 (304)
Neoplasms of sweat glands and the breast may be morphologically and immunophenotypically similar. A recent study showed that TRPS1 staining is a highly sensitive and specific marker for breast carcinoma.
Hatice B. Zengin +5 more
doaj +2 more sources
Enhancers are context-specific regulators of expression that drive biological complexity and variation through the redeployment of conserved genes.
Daniel Aldea +7 more
doaj +2 more sources
Both cholinergic and adrenergic stimulation can induce sweat secretion in human eccrine sweat glands, but whether cholinergic and adrenergic stimulation play same roles in rat eccrine sweat glands is still controversial.
Lei Zhang +4 more
openalex +3 more sources
Glucose Metabolism of the Isolated Eccrine Sweat Gland [PDF]
Kenzo Sato, Richard L. Dobson
openalex +2 more sources
De Novo Epidermal Regeneration Using Human Eccrine Sweat Gland Cells: Higher Competence of Secretory over Absorptive Cells [PDF]
Luca Pontiggia +8 more
openalex +2 more sources
The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications. [PDF]
Non-invasive and accurate access of biomarkers remains a holy grail of the biomedical community. Human eccrine sweat is a surprisingly biomarker-rich fluid which is gaining increasing attention.
Sonner Z +10 more
europepmc +2 more sources
A genetic basis of variation in eccrine sweat gland and hair follicle density. [PDF]
Kamberov YG +6 more
europepmc +2 more sources
Matrigel‐Induced Tubular Morphogenesis of Human Eccrine Sweat Gland Epithelial Cells [PDF]
Xia Lei +4 more
openalex +2 more sources
Secretion of a potassium‐rich fluid by the secretory coil of the rat paw eccrine sweat gland
Fusako Sato, Kenzo Sato
openalex +3 more sources
Body Biofluids for Minimally-Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential. [PDF]
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Rao LT, Mandal CK, Patolsky F.
europepmc +2 more sources

